MAESTRIA:
Machine Learning Artificial Intelligence Early Detection STroke Atrial Fibrillation.
MAESTRIA - AFNET 10:
Clinical cohorts for validation of new digital biomarkers.
PATIENTS
MAESTRIA
Start of the project: 1st of March 2021
Duration of the project: 60 months
MAESTRIA - AFNET 10
Start of the study: approximately October 2022
Duration of the study: 30 months
Status as of 28th of June 2022
600
Planned number of participants
PARTICIPATING COUNTRIES
Germany, France, The Netherlands, United Kingdom, Spain, Greece, USA, Canada.
Overall Responsibility
Sobonne University, Paris, France
Chief Investigator (MAESTRIA)
Prof. Dr. Stéphane Hatem, Paris, France
Scientific leader (MAESTRIA-AFNET 10)
Prof. Andreas Götte, Paderborn, Germany